Mirae Asset Global Investments Co., Ltd. Point Biopharma Global Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 26, 2023	BUY	$6.67 - $9.71 $3,214 - $4,680	482 Added 0.75%	64,680 $431,000
Q2 2023 Aug 10, 2023	BUY	$6.86 - $10.86 $1,557 - $2,465	227 Added 0.35%	64,198 $581,000
Q1 2023 May 04, 2023	BUY	$6.78 - $8.1 $225,550 - $269,462	33,267 Added 108.35%	63,971 $465,000
Q3 2022 Nov 10, 2022	BUY	$7.24 - $10.31 $68,924 - $98,151	9,520 Added 44.94%	30,704 $237,000
Q2 2022 Jul 26, 2022	BUY	$5.6 - $9.5 $118,630 - $201,248	21,184 New	21,184 $144,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.